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Introduction
Performing procedures in children are difficult due to no cooperation and fear of 
procedures. Therefore, sedation and sleep are frequently induced using some agents 
as pre procedure medication in children. EEG recording is a long duration procedure 
and needs patient cooperation for device setup and performing the procedure. 
Because of long duration of the EEG recording, many children lose their cooperation 
and begin to move or cry during the procedure and due to lack of cooperation, EEGs 
are recorded poorly and are difficult to interpret by neurophysiologists (1,2).
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Abstract
Objective 
Electroencephalography (EEG) recording is a long duration procedure 
that needs patient’s cooperation for device setup and performing the 
procedure. Many children lose their cooperation during this procedure. 
Therefore, sedation and sleep are frequently induced using a few agents 
as pre procedure medication in children before EEG recording. We aimed 
to compare the sedative effects of oral midazolam versus chloral hydrate 
before the procedure along with their impacts on EEG recording in children.
Materials & Methods
A randomized trial was carried out to compare the sedative effects of oral 
midazolam versus chloral hydrate and their impacts on EEG recording in 
children. A total of 198 children (100 in the midazolam group and 98 in the 
chloral hydrate group) were enrolled in the study and randomly allocated to 
receive either oral moidazolam or chloral hydrate.
Results
Oral midazolam had superiority neither in sleep onset latency nor in 
sleep duration when compared to chloral hydrate. Moreover, the yield of 
epileptiform discharges in the chloral hydrate group was more than the 
midazolam group.
Conclusion
The results of this study showed that both chloral hydrate 5% (one ml/kg) 
and oral midazolam (0.5 mg/kg) could be administered as a pre medication 
agent for EEG recording in children. However, oral midazolam at this dose 
had no advantage compared with chloral hydrate.
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An ideal pre medication for inducing sedation and sleep 
in children who are candidates for EEG recording should 
rapidly induce sleep and because of long duration of EEG 
recording, this agent should have a long acting hypnotic 
effect. Furthermore, such agent should also have no or 
minimal effect on the EEG background and paroxysmal 
transients in the EEG. Because of ease of use, oral 
medications are far superior to parenteral agents (1-3). 
Chloral hydrate is a sedative and hypnotic medication 
that has been used since 1869. This medication has been 
used for a long time in our center to induce sleep in 
children who are referred for EEG recording and have no 
cooperation for procedure performing. Chloral hydrate 
has two active metabolite, Trichloroethanol (TCE) and 
Trichloroacetic acid (TCA). By an unknown mechanism, 
TCE exerts sedative and hypnotic effects of chloral 
hydrate on the CNS. Chloral hydrate has long been used 
as pre-medication for EEG recording, however, this 
medication has many known adverse effects such as; 
nausea, vomiting, agitation, ataxia, prolonged sedation, 
delayed apnea events, gastric irritation, potential 
carcinogenicity, and genotoxicity even as a single low 
dose (1,3,4).
Midazolam is a sedative, hypnotic, and anticonvulsant 
agent, which has been used as a pre medication agent 
in many procedures in children (5-10). Recently, oral 
solution of this medication has been available in our 
country (Iran), and anecdotal reports have proposed 
its efficacy as a pre medication in intubation and 
endoscopy. However, to the best of our knowledge, no 
study has yet been performed to show the superiority of 
oral midazolam as a pre medication for EEG recording 
in children. Therefore, we carried out a randomized trial 
to compare the sedative effects of oral midazolam versus 
chloral hydrate and their impacts on EEG recording in 
children.
Materials & Methods
Study location, sample, and design
Our study was conducted between May 2010 and May 
2011 in a major University Paediatric Hospital in Tehran, 
Iran. We enrolled children aged between one month and 
ten years who were referred for EEG recording and were 
uncooperative with the device setup or were referred to 
our center for sleep EEG recording. We excluded children 
if they had hypersensitivity to midazolam or chloral 
hydrate, hepatic disease, peptic ulcer, respiratory disease 
or received medications that had dangerous interactions 
with midazolam or chloral hydrate. 198 Consecutive 
patients were enrolled and randomly assigned to receive 
either oral moidazolam (midazolam group, n=100) or 
chloral hydrate (chloral group, n=98). Parents were 
asked to awaken their children at 6.00 am and not to let 
them fall asleep until the time of EEG recording.
Midazolam was given at a dose of 0.5 mg/kg and 
Chloral hydrate 5% was given at a dose of one ml/kg 
of body weight orally, one hour before EEG recording. 
A trained staff filled out a questionnaire for each patient 
to collect the following data: neurological diagnosis, 
sleep onset latency, sleep duration, drowsiness time, and 
adverse events that occurred in the first 24 h after EEG 
recording. We used an analogue EEG machine (Nihon 
Kohden) in our center for EEG recording, and EEG was 
recorded using 21 scalp electrodes based on the standard 
international 10 20 system. A trained and skilled child 
neurophysiologist interpreted the recorded EEGs.
Ethics
The study protocol was approved by the Ethics Committee 
of Tehran University of Medical Sciences, and a written 
informed consent approved by the Institutional Review 
Board was obtained from all parents prior to enrolment 
in the study. The trial was registered with the Ethics 
Committee of Tehran University of Medical Sciences 
prior to any patient enrolment.
Statistical analysis
Based on previous data and using two-tailed tests, the 
sample size was calculated keeping Type I error (α)=0.05 
and Type II error (β)=0.2. The necessary sample size was 
calculated to be at least 100 patients in each group in 
order to detect any difference between two groups, with 
the power of the test set at 80%. Data were recorded in 
forms previously explained to trained staff. Recorded 
data were assessed for normal distribution using the 
Shapiro Wilk test. Statistical analysis was performed 
using independent samples t-test and Mann Whitney 
Rank Sum test for continuous data. Categorical variables 
were analyzed using Fisher exact and 2 Tests. A value 
of p<0.05 was considered significant. A biostatistician 
who was blinded to the study groups performed statistical 
analysis.
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group and between 20 and 95 min (a median of 32 
min) in the chloral hydrate group [Mann-Whitney 
U Statistic=1940.000, T=6791.000, n (small)=98 n 
(big)=100; (p<0.001)]. Sleep duration was significantly 
longer in the chloral hydrate group compared to 
midazolam group [between 12 and 38 min (a median of 
25.5 min) in the midazolam group and between 56 and 
98 min (a median of 66.5 min) in the chloral hydrate 
group [Mann-Whitney U Statistic=0.000, T=14651.000, 
n(small)=98 n(big)=100; (p<0.001)]. Drowsiness time 
was significantly shorter in the midazolam group than 
chloral hydrate [between 2 and 9 min (a median of 6 min) 
in the midazolam group and between 21 and 36 min (a 
median of 32 min) in the chloral hydrate group [Mann-
Whitney U Statistic=0.000, T=14651.000 n(small)=98 
n(big)=100; (p<0.001)] (Table 1).
medication. 
Discussion
EEG recording usually needs induced sedation and 
sleep in children who uncooperative with the device 
setup and EEG recording. The ideal pre medication for 
EEG recording in children should rapidly induce sleep 
and because of long duration of the EEG recording 
should have a long acting hypnotic effect. Furthermore, 
this pre medication agent should also have no or 
minimal effect on EEG background and paroxysmal 
transients in EEG (1-3). 
Results of the present study indicated that both chloral 
hydrate and oral midazolam showed the characteristics 
of a suitable pre medication agent for EEG recording 
Results
The midazolam group consisted of 47 boys and 53 
girls, with the median age of 4 years and a range from 2 
month to 9 years. The chloral hydrate group consisted 
of 48 boys and 50 girls with the median age of 4 years 
with a range of 3 months to 10 years. In the midazolam 
group, 80 children were referred for EEG recording due 
to seizure disorders, 15 because of developmental delay, 
and five due to autistic feature. In the chloral hydrate 
group, 79 children were referred for EEG recording 
due to seizure disorders, 13 for developmental delay, 
and six due to autism. No significant difference was 
seen between two groups concerning referral etiologies 
( = 0.22, df=2; p=0.896). 
Sleep onset latency was significantly shorter in the 
chloral hydrate group than midazolam group [between 
45 and 98 min (a median of 58 min) in the midazolam 
Abnormal epileptiform discharges were significantly 
more reported in children who sedated by chloral 
hydrate than midazolam [85 children in chloral hydrae 
group (87%) and 45 children in midazolam group 
(45%), =36.404, df =1; p<0.001]. The most frequent 
drug effect on EEG was generalized fast beta activity 
followed by slow delta activity in temporal regions. 
These drug’s effects on EEG were significantly more 
reported in children who received midazolam as pre 
medication agent [40 children in chloral hydrae group 
(41%) and 70 children in midazolam group (70%), 
=15.911, df=1; p< 0.001] No significant adverse 
reactions were seen in both groups but two children 
in the midazolam group developed short duration 
irritability and were improved without using other 
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20-95 (32) 45-98 (58) <0.001 56-98 (66.5) 12-38 (25.5) <0.001 21-36 (32) 2-9 (6) <0.001
a: Values are expressed in minutes
b: P-value using Mann-Whitney U test
Table 1. Sleep Characteristics Between Groups of Chloral Hydrate and Oral Midazolam
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in children.
However, oral midazolam had superiority neither in 
sleep onset latency nor in sleep duration when compared 
to chloral hydrate. Moreover, the yield of epileptiform 
discharges in the chloral hydrate group was more than 
the midazolam group. On the other hand, results of this 
study showed that drowsiness time from midazolam was 
shorter than chloral hydrate, although this effect has no 
place in EEG recording and adds some difficulty for 
parents to handle their children after EEG recording. 
Therefore, based on the results of this study, chloral 
hydrate is still a more suitable choice as a pre medication 
agent for EEG recording in children.
The results of this study are comparable with those 
of previous studies in children. In a similar study, 
melatonin versus chloral hydrate was assessed as pre 
medication agents for EEG recording in children. In 
the mentioned study 384 children aged 1 to 72 months 
were enrolled to evaluate sleep onset latency, sleep 
duration, and drowsiness time along with the yield of 
epileptiform discharges (1). Results of that study showed 
that both melatonin and chloral hydrate are valuable 
pre medication agents in children. Other studies with 
different methodologies in children showed the beneficial 
effects of oral midazolam such as decreased anxiety 
and acceptable sedation before upper gastrointestinal 
endoscopy or intubation (2,3,5-14).
To the best of our knowledge, our study is the first study 
that compares the effects of oral midazolam with those 
of chloral hydrate. However, the results of our study 
should be interpreted in the face of certain limits. We 
administered oral midazolam at a dose of 0.5 mg/kg for 
each children and this dose may explain longer sleep 
latencies and shorter sleep durations in the children of 
midazolam group. We think higher doses could improve 
sleep latency and sleep duration.  
In conclusion, results of our study indicate that both 
chloral hydrate 5% (one ml/kg) and oral midazolam (0.5 
mg/kg) can be administered as a pre medication agent for 
EEG recording in children. However, oral midazolam at 
this dose had no superiority to chloral hydrate.
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